AbbVie (Germany) (Q333253)

From geokb

Revision as of 18:19, 9 September 2024 by Sky (talk | contribs) (‎Changed an Item: added subsidiary relationship based on OpenAlex/ROR data)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

company organization in Wiesbaden, Germany

Language	Label	Description	Also known as
English	AbbVie (Germany)	company organization in Wiesbaden, Germany

Statements

0 references

addresses subject

Rheumatoid Arthritis Topics

144

1 reference

https://openalex.org/I4210128201

Genetics and Treatment of Inflammatory Bowel Disease

134

1 reference

https://openalex.org/I4210128201

Hemophagocytic Lymphohistiocytosis and Related Disorders

117

1 reference

https://openalex.org/I4210128201

Epidemiology and Treatment of Microscopic Colitis

94

1 reference

https://openalex.org/I4210128201

Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia

75

1 reference

https://openalex.org/I4210128201

Reciprocal Development of TH17 and Treg Cells

69

1 reference

https://openalex.org/I4210128201

Drug Delivery Systems

66

1 reference

https://openalex.org/I4210128201

Classification and Treatment of Spondyloarthritis

64

1 reference

https://openalex.org/I4210128201

Mechanisms of Alzheimer's Disease

62

1 reference

https://openalex.org/I4210128201

Protein Aggregation and Biopharmaceutical Stability

55

1 reference

https://openalex.org/I4210128201

Immunogenicity of Biosimilar Therapeutics in Drug Development

50

1 reference

https://openalex.org/I4210128201

Systemic Lupus Erythematosus and Antiphospholipid Syndrome

47

1 reference

https://openalex.org/I4210128201

Hepatitis C Infection and Treatment

46

1 reference

https://openalex.org/I4210128201

Role of Microglia in Neurological Disorders

39

1 reference

https://openalex.org/I4210128201

Therapeutic Antibodies: Development, Engineering, and Applications

39

1 reference

https://openalex.org/I4210128201

Crystallization Processes and Control

36

1 reference

https://openalex.org/I4210128201

Lymphoid Neoplasms

34

1 reference

https://openalex.org/I4210128201

Developmental Pharmacology in Pediatric Drug Use

32

1 reference

https://openalex.org/I4210128201

Supporting Health Care Transition from Adolescence to Adulthood

30

1 reference

https://openalex.org/I4210128201

Health Economics and Quality of Life Assessment

29

1 reference

https://openalex.org/I4210128201

Chiral Separation in Chromatography

28

1 reference

https://openalex.org/I4210128201

Atopic Dermatitis and Skin Microbiome

27

1 reference

https://openalex.org/I4210128201

Epidemiology and Treatment of Childhood Leukemia

26

1 reference

https://openalex.org/I4210128201

Molecular Mechanisms of Synaptic Plasticity and Neurological Disorders

25

1 reference

https://openalex.org/I4210128201

Genetic Basis of Primary Immunodeficiency Disorders

24

1 reference

https://openalex.org/I4210128201

coordinate location

50°4'14"N, 8°14'56"E

1 reference

https://openalex.org/I4210128201

Federal Republic of Germany

1 reference

https://openalex.org/I4210128201

0 references

Research Organization Registry ID

0 references

is subsidiary of

AbbVie (United States)

1 reference

https://openalex.org/I4210128201

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q333253&oldid=1263590"